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ABSTRACT 
The acute phase response induced by bacterial pyrogens, but not by viral pyrogens, 
has been thoroughly investigated. Polyinosinic:polycytidylic acid (poly I:C) is a 
synthetic viral pyrogen that is used to simulate viral infection. This dissertation 
describes how I determined an effective peripheral route and dose of administration 
of poly I:C to rats. Thereafter I investigated whether poly I:C induced sickness 
behaviour, and whether repeated administration of poly I:C resulted in the 
development of tolerance.  Intraperitoneal administration of at least 1000µg/kg poly 
I:C induced fevers in rats, but not sickness behaviour. Unlike repeated administration 
of LPS, repeated administration of poly I:C in rats did not result in the development 
of tolerance.  
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1. INTRODUCTION 
Fever is one of the most common symptoms observed in an animal which has been 
infected with a pathogenic micro-organism, whether bacterial, viral or protozoal in 
origin (Chuang et al.: 1990, Mitchell & Laburn: 1997, Luker et al.: 2000, Cartmell et 
al.: 2002, Engeland et al.: 2003). In addition to an increase in body temperature, there 
are a variety of other brain-mediated, behavioural changes, collectively referred to as 
sickness behaviour (Bluthe et al.: 1992, Mitchell & Laburn: 1997, Engeland et al.: 
2003, Dantzer: 2004), which accompany fever. Sickness behaviour includes malaise, 
hypoactivity, fatigue, hypophagia, an increase in slow wave sleep, a decrease in 
sexual behaviour, anhedonia, hyperalgesia and activation of the hypothalamic-
pituitary-adrenal (HPA) axis (Bluthe et al.: 2000, Bluthe et al.: 2001, Dantzer: 2004, 
Vollmer-Conna et al.: 2004).  Fever combined with these behavioural changes is 
known as the acute phase response (APR) (Mitchell & Laburn: 1997). The 
components of the APR are not specific to any particular sex (Engeland et al.: 2003) 
or animal species, but are seen in humans and a variety of animals (Hart: 1988a) 
including invertebrates (LeGrand: 2000).  
 
1.1 Mediators of the Acute Phase Response 
The administration of an exogenous pyrogen results in a cascade of events, beginning 
with the activation of the host’s peripheral phagocytic cells, which include blood 
monocytes, tissue macrophages and a variety of other cells. These immune-competent 
cells produce and secrete a family of polypeptides called cytokines, which themselves 
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are potent mediators of the acute phase response and are also referred to as 
endogenous pyrogens (Kluger et al.: 1995, Mitchell & Laburn: 1997, Engeland et al.: 
2003).  
 
The important cytokines mediating the acute phase response induced by a bacterial 
product are interleukin-1 (IL-1 and ), interleukin-6 (IL-6) and tumour necrosis 
factor alpha (TNF- ) (Kluger et al.: 1995, Luheshi: 1998, Swiergiel & Dunn: 1999, 
Bluthe et al.: 2000, Engeland et al.: 2003, Conti et al.: 2004, Dantzer: 2004). 
Cytokines regulate the release of other cytokines causing a hierarchical response 
(Swiergiel & Dunn: 1999). For example, in vitro studies have shown that 
administration of the bacterial pyrogen, lipopolysaccharide (LPS) in experimental 
animals results in the release of TNF- and IL-1 which induce the secretion of each 
other and both induce the secretion of IL-6.  IL-6 in turn, however, down-regulates 
the secretion of TNF- and IL-1 (Swiergiel & Dunn: 1999, Blatteis: 2004). The 
APR is centrally mediated; specific cytokine receptors exist throughout the brain 
(Engeland et al.: 2003) and central administration of cytokine antagonists, such as the 
IL-1 receptor antagonist (IL-1ra) in rats, attenuate many of the components of the 
APR (Bluthe et al.: 1992, Dantzer: 2004).  
 
The endogenous pyrogens elicit their effects by catalyzing the formation of 
prostaglandins (PGs) in the central nervous system (CNS) (Roth & de Souza: 2001).  
The cyclooxygenase (COX) enzyme system is critically important in the formation of 
 3 
PGs (Roth et al.: 2002, Botting: 2006), as these enzymes initiate the first step in the 
transformation of arachidonic acid to prostanoids (Lefkowith: 1999, Botting: 2006). 
The principal action of antipyretic and non-steroidal anti-inflammatory drugs 
(NSAIDs) therefore rests in their ability to inhibit the enzyme COX and interrupt the 
synthesis of inflammatory PGs, thereby attenuating the APR (Ziel & Krupp: 1975, 
Aronoff & Neilson: 2001, Dantzer: 2004, Botting: 2006). PGs of the E2 series are 
believed to be the central and probably the key mediator of fever and sickness 
behaviour (Roth & de Souza: 2001, Dantzer: 2004). The theory that PGE2 is the 
central and key mediator of the APR stems from studies reporting that 
microinjections of PGE2 administered centrally in experimental animals, almost 
immediately results in a monophasic fever (Ziel & Krupp: 1975, Abul et al.: 1997, 
Blatteis: 2004) which can be inhibited with the administration of NSAIDs (Ziel & 
Krupp: 1975, Lefkowith: 1999, Blatteis: 2004). 
 
1.2 Fever and Sickness Behaviour 
Fever is a component of the APR and is defined as a rise in core body temperature 
induced by a controlled increase in the so-called temperature “set-point” due to 
changes in the neuronal activity in the preoptic area of the hypothalamus (Conti et al.: 
2004). The magnitude and duration of the fever is dependent on the nature of the 
pyrogen, the route of administration and the dose of the pyrogen (Cartmell et al.: 
2002), as well as the species and strain of the experimental animals used (Kimura et 
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al.: 1994, Romanovsky et al.: 1996, Plata-Salaman et al.: 1998, Kamerman & Fuller: 
2000, Grinevich et al.: 2001).  
 
The febrile response is one of the best examples of the communication between the 
immune system and the brain (Kluger et al.: 1995, Luheshi: 1998, Dantzer: 2004).  
The immune system functions as a sensory organ relaying information to the brain 
and other parts of the body via signals such as the pro-inflammatory cytokines (Kent 
et al.: 1992, Dantzer: 2004).  The raised body temperature reached during fever in 
turn stimulates immune responses (Dinarello & Wolff: 1982, Kent et al.: 1992) and 
decreases the proliferation of pathogens which are thermo-sensitive (Kent et al.: 
1992).  
 
Previously, sickness behaviour was thought to be the result of the incapacitating 
process that occurs during infection (Kent et al.: 1992, Konsman et al.: 2002). 
Evidence now indicates that the behavioural changes observed during infection are 
not maladaptive but are a crucial part of the natural homeostatic reaction that the 
body uses to fight infection (Hart: 1988b, Kent et al.: 1992, Konsman et al.: 2002).  
 
The most extensively used model to study the APR and to induce reproducible febrile 
responses has been to inject healthy laboratory animals with exogenous pyrogens, 
particularly bacterial pyrogens.   
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1.3 Bacterial Pyrogens 
The most commonly used bacterial product is lipopolysaccharide (LPS), the 
pyrogenic moiety of Gram-negative bacteria (Plata-Salaman et al.: 1998, Cartmell et 
al.: 2002, Engeland et al.: 2003). LPS forms the major part of the outer cell wall of 
Gram-negative bacteria that is released after bacteriolysis. Another bacterial product 
is muramyl dipeptide (MDP), the pyrogenic moiety of Gram-positive bacteria 
(Engeland et al.: 2003).  During phagocytosis other bacterial cell wall constituents 
which are abundant in Gram-positive bacteria are released after bacteriolysis.  MDP 
is the minimal structure from Gram-positive bacteria having immune-stimulating 
properties (Engeland et al.: 2003).   
 
Although Gram-positive and Gram-negative bacteria share some common 
mechanisms of immuno-competent cell activation, as CD-14 receptors on circulating 
phagocytes are capable of recognizing both LPS and MDP (Engeland et al.: 2003), 
there are quite distinct differences in the effects induced by these two pyrogens.  It is 
well documented that there are differences in the pattern of fevers induced by Gram-
negative and Gram-positive bacteria, for example, administration of Gram-negative 
bacteria can result either in a biphasic fever or monophasic fever under different 
conditions in laboratory animals, whereas administration Gram-positive bacteria 
results in a monophasic fever response (Romanovsky et al.: 1996, Condrad et al.: 
1997, Cartmell et al.: 2002, Engeland et al.: 2003).  Gram-positive and Gram–
negative bacteria also induce different molecular and behavioural effects in the brain 
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(Plata-Salaman et al.: 1998). For example, LPS is more potent than MDP in inducing 
hypophagia and in up-regulating TNF- and IL–1 mRNAs in certain regions of the 
brain (Plata-Salaman et al.: 1998). MDP on the other hand, is more potent in up-
regulating the expression of the anti-inflammatory cytokine, IL-1ra, mRNAs centrally 
(Plata-Salaman et al.: 1998).  
 
A further characteristic of LPS which is not attributed to MDP, is that repeated 
administration of LPS in animals results in an attenuation of the febrile effects after 
as little as one injection (O'Reilly et al.: 1988, Roth et al.: 1997), a phenomenon 
referred to as endotoxin tolerance. In contrast to repeated administration of LPS, 
repeated administration of the Gram-positive pyrogen, MDP, does not readily result 
in the development of tolerance to the febrile effects of this pyrogen (Soszynski et al.: 
1991, Roth et al.: 1997, Zeisberger & Roth: 1998). Thus there appear to be 
differences in the characteristics of the acute phase response induced by Gram-
negative and Gram-positive bacterial products.  
 
Another class of exogenous pyrogens, whose effects have received limited research, 
are those of viral origin.  
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1.4 Viral Pyrogens 
While the mechanisms mediating fever and sickness behaviour in response to a 
bacterial challenge, particularly in response to LPS administration, have been 
thoroughly investigated and reported on (Hart: 1988b, Kluger et al.: 1995, Mitchell & 
Laburn: 1997, Engeland et al.: 2003, Conti et al.: 2004), the mechanisms mediating 
virally-induced infection have yet to be fully elucidated.  If the pyrogenic effects of 
different bacterial pyrogens differ, it is reasonable to speculate that fevers induced by 
a viral pyrogen would differ from fevers induced by a bacterial pyrogen.  
 
Much of our knowledge of the interaction between viruses and cells has been 
obtained through studies with various models for viral infection. A candidate 
substance for inducing the pyrogenic and behavioural effects to many viral infections 
is double-stranded ribonucleic acid (dsRNA), which is generated by most viruses as a 
result of viral replication (Jacobs & Langland: 1996).  The polyinosinic:polycytidylic 
acid copolymer (poly I:C) is a synthetic viral dsRNA and has been administered to 
laboratory animals, primarily rabbits, as a model to simulate virally-induced 
infections (Lindsay et al.: 1969, Homan et al.: 1972, Won & Lin: 1988, Kimura-
Takeuchi et al.: 1992, Katafuchi et al.: 2003). Poly I or poly C, administered as 
individual polymers to rabbits does not result in a febrile response, indicating a 
synergy between these two polymers (Lindsay et al.: 1969). 
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As with bacterially-induced infection, the induction of a viral infection results in a 
strong host-response (Mogensen & Paludan: 2001).  The interaction between viral 
surface proteins and specific cellular receptors initiates a cellular reaction causing the 
production and release of cytokines (Mogensen & Paludan: 2001). The effect can be 
simulated by the administration of poly I:C which induces the production of 
cytokines by macrophages and the activation of macrophages, via the toll-like 
receptor TLR-3 (Alexopoulou et al.: 2001, Pruett et al.: 2003, Fortier et al.: 2004). 
 
Exposure to viruses induces a similar cytokine cascade as bacterially-induced 
infection (Majde: 2000), but the primary cytokines involved in viral infections are the 
interferons (IFNs). Thus poly I:C is referred to as an interferon-inducer (Won & Lin: 
1988, Davidson et al.: 2001). IFNs mediate immune reactions and cause central 
nervous system-mediated effects, such as fever, by activating PGs (Won & Lin: 
1988). Therefore, similar to a bacterial infection, the effects of a viral infection, such 
as fever, are also dependent on the crucial role played by cytokines and 
prostaglandins.  
 
There remains a lot of controversy in the exact mechanisms by which poly I:C 
mediates its effects.  A study performed on rabbits showed that the APR induced after 
administration of viral pyrogens, comparable to that after administration of bacterial 
pyrogens, causes PGE2 to enter the brain from the peripheral circulation resulting in 
the fever response (Davidson et al.: 2001). Poly I:C-induced production of PGE2 was 
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confirmed by studies using anti-inflammatory drugs, such as ketoprofen, which 
resulted in an attenuation in the febrile response induced by poly I:C (Ziel & Krupp: 
1975, Rotondo et al.: 1987, Won et al.: 1991, Aronoff & Neilson: 2001).  Chuang et 
al. (1990) showed with the use of a somatostatin antagonist (SS-14) that a 
somatostatinergic pathway in the rat hypothalamus may mediate the fever induced by 
interferon or its inducer poly I:C.  Another study reported that poly I:C may act to 
induce fever through the endogenous release of noradrenalin from the rat 
hypothalamus (Liu et al.: 1989). 
 
Poly I:C- and LPS-induced infections differ somewhat in the APRs they induce, for 
example, although the sensitivity of rabbits to these two stimuli is similar in terms of 
pyrogencity when administered intravenously, the profile of the febrile response 
differs, with LPS-induced fevers peaking after three hours and diminishing by six 
hours, while administration of poly I:C results in a more extended fever response 
lasting longer than six hours (Kimura et al.: 1994).  A possible reason for the 
differences in the APRs induced by LPS and poly I:C in laboratory animals is the 
different cytokine profiles that are involved, such as the fact that administration of 
LPS does not cause an increase in IFN-, whereas administration of poly I:C does 
(Kimura et al.: 1994).  Another difference in the APR induced by LPS and poly I:C is 
that LPS induced anorexia has been shown to be IL-1 and PG dependent (Swiergiel & 
Dunn: 1999) whereas poly I:C-induced anorexia, is not IL-1 dependent (Fortier et al.: 
2004).  
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1.5 Study Objectives 
Our knowledge of the molecular mechanisms mediating viral infection has grown 
considerably over the years, but there are still many important unanswered questions. 
Differences in APRs accompanying these two classes of infection, specifically 
regarding the pyrogenic and behavioural effects, have received limited study. The 
high prevalence of viral infection in humans underlines the importance of better 
understanding the mechanisms mediating virally-induced infection. 
 
The objectives of this study were to compare different aspects of bacterially-induced 
infection to a virally-induced infection.  Before I could proceed with my objectives 
however, I firstly had to determine an effective dose and route of administration of 
poly I:C to induce fevers in rats, a species seldom used to study the effects of poly 
I:C.  My first objective was to compare the body temperature responses induced by a 
viral (poly I:C) and bacterial (LPS) pyrogen as well as an aspect of sickness 
behaviour, namely the suppression in cage activity.  The next objective was to 
determine whether, similar to repeated administration of LPS, repeated night-time 
administration of poly I:C results in the development of tolerance to the respective 
pyrogen’s thermal and behavioural effects.  
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2. GENERAL METHODS 
2.1 Animals 
Adult male Sprague-Dawley rats with an initial body mass of 180-220g were used in 
the experiments. The animals were individually housed in perspex cages in a 
temperature controlled environment (22°C ± 1°C). The rats were kept on a 12:12h 
light:dark cycle (lights on at 07:00). Standard rat food pellets (Epol, Johannesburg, 
South Africa) and water were available ad libitum throughout the experimental 
period. Cages were cleaned every four days and at the same time the animals were 
weighed. All procedures and protocols were approved by the Animal Ethics and 
Screening Committee of the University of the Witwatersrand (AESC 2004/35/4, 
2004/78/4, 2004/79/4).  
 
2.2  Measurement of Body Temperature 
Seven days before the start of each experiment, all rats had sterile, wax-coated 
temperature-sensitive radiotelemeters (DataScience, St Paul, USA) implanted into 
their peritoneal cavities for the continuous measurement of body temperature. The 
surgical procedures were performed under anaesthesia using ketamine hydrochloride 
(Anaket-V, Bayer, SA, 80mg/kg) and xylazine (Chanazine, Bayer, SA, 4mg/kg). 
Before surgery, telemeters were calibrated in a water bath against a precision quartz-
crystal thermometer (Quat 100, Heraeus, Germany), such that abdominal temperature 
could be measured to an accuracy of 0.1oC. After implantation, the frequency emitted 
by each telemeter was monitored by  a receiver plate (RTA 500 Mini Mitter, USA) 
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which was placed under each rat’s cage and fed into a peripheral processor (Datacol-3 
Automated Data Acquisition System, Mini Mitter) connected to a personal computer. 
The output was expressed in degrees centigrade and body temperature recordings 
were made at 5 min intervals. 
 
2.3 Measurement of Cage Activity 
The Data Acquisition System also allowed us to continuously monitor cage activity 
of the rats based on the detection of the movement of the telemeter over the receiver 
plate, which was the size of the cage. Activity counts were accumulated over 5 min 
intervals and were consolidated to match the temperature data. 
 
2.4 Pyrogenic Agents 
Poly I:C (Lot No 033K4011 and 074K4051, Sigma, USA) was prepared by 
dissolving the pyrogen in sterile, pyrogen-free saline (0.9%NaCl). Three doses of 
poly I:C were prepared (500µg/kg, 1000µg/kg and 2000µg/kg) and administered at a 
final volume of approximately 0.3ml. For any particular study the same batch of poly 
I:C was used throughout that experimental period. 
 
LPS (from E. coli, serotype 0111:B4, Sigma, USA) was prepared by dissolving the 
pyrogen in sterile pyrogen-free saline.  One dose of LPS was prepared (100µg/kg), 
and administered intramuscularly at a final volume of approximately 0.3ml. The 
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intramuscular route of injection and dose chosen of LPS have previously been used to 
induce fevers in rats (Kamerman & Fuller: 2000, Kamerman et al.: 2002). A study 
performed in rabbits showed that the sensitivity to intraperitoneal administration of 
LPS is much lower compared to intramuscular administration (Cartmell et al.: 2002).  
All animals which served as controls were injected with sterile saline. 
 
2.5 Data Analysis 
Data are expressed as mean (±SD). The body temperature for each group of rats was 
averaged at 15 min intervals and consolidated to represent a 24h period from 07:00 to 
07:00. One-way analysis of variance (ANOVA) followed by the Tukèy post hoc test 
was used to detect significant differences between the experimental groups (receiving 
pyrogen) and the control groups (receiving saline). Mean body temperatures of each 
group were calculated and compared. Differences in mean body temperature 
compared to saline treated groups were also calculated and compared. To obtain 
thermal response indices (TRIs), I calculated differences in the responses of each rat 
by calculating the area under the temperature curve vs. time.  The TRI is a useful 
measure of temperature changes as it takes into account not only the magnitude of the 
temperature rise but also the duration. 
 
The cage activity of each group of rats was averaged for 12 hours from lights on 
(07:00) to lights off (19:00) and expressed as a mean 12h day-time activity. Mean 
12h night-time activity was calculated from lights off (19:00) to lights on (07:00). 
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One-way ANOVA followed by the Tukèy post hoc tests was used to detect 
significant differences between the experimental groups and the control groups for 
the day-time and night-time activity. P values of < 0.05 were considered significant.  
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3. AN EFFECTIVE DOSE AND ROUTE OF POLY I:C 
ADMINISTRATION IN RATS  
 
3.1 Introduction  
 
Administration of exogenous pyrogens in laboratory animals at different doses via 
different routes of administration results in fevers with differing profiles (Cartmell et 
al.: 2002). Often an effective pyrogen is rendered ineffective when administered at an 
inappropriate dose or route (Cartmell et al.: 2002). The most commonly used 
exogenous pyrogen to induce symptoms of infection is LPS, the pyrogenic moiety 
from Gram-negative bacteria. The mechanisms mediating the effects induced by 
Gram-negative bacteria have been thoroughly investigated by administering LPS at 
various doses and routes of administration (Cartmell et al.: 2002) and in a variety of 
animal species and strains, with rats being the most extensively used (Roth et al.: 
1994, Tripp et al.: 1998, Kamerman & Fuller: 2000, Luker et al.: 2000, Cartmell et 
al.: 2002).  The same, however, is not true for viral pyrogens such as poly I:C.   
Studies investigating the effects of poly I:C and the mechanisms mediating virally 
induced infection have been primarily performed on rabbits (Lindsay et al.: 1969, 
Lin: 1981, Won et al.: 1991, Kimura et al.: 1994), or via a central route of delivery in 
rats (Liu et al.: 1989, Chuang et al.: 1990). 
 
There exists a species variation in the pyrogenicity of poly I:C when administered via 
different routes.  Lindsay et al. (1969) reported that poly I:C is highly pyrogenic in 
rabbits, resulting a 0.8oC increase in body temperature, after intravenous 
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administration at a dose of only 0.5µg/kg.  Whereas, another study reported that poly 
I:C administered intravenously at a dose of 0.25µg/kg  results in an increase in body 
temperature of 1.2oC (Kimura et al.: 1994).  Intranasal administration of poly I:C at a 
dose of 2000µg/kg to rabbits also resulted in a fever with a 1.2oC increase in body 
temperature (Lindsay et al.: 1969).  Microinjections of poly I:C into the anterior 
hypothalamic area produces fevers in rabbits (Liu et al.: 1989).  
Intracerebroventricular injections of poly I:C at a dose of 1ng does not elicit an 
increase in core body temperature whereas a dose of 10ng and 100ng result in a 0.7oC 
and 1oC  increase in temperature respectively (Kimura et al.: 1994). 
 
In guinea pigs, intravenous administration of poly I:C at a dose of 30µg/kg results in 
a 0.6oC increase in body temperature whereas injections given intraperitoneally 
required a dose of 50µg/kg to evoke a similar response (Li et al.: 2000). A dose of 
800µg/kg is required to result in a 1.2oC increase in body temperature when 
administered intramuscularly (Lindsay et al.: 1969).  
 
In rats intrahypothalamic injections of poly I:C also cause fever (Liu et al.: 1989, 
Chuang et al.: 1990), as does intravenous administration but with intravenous 
administration there is a longer latency period compared to intrahypothalamic 
administration (Liu et al.: 1989).  
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The aim of this study was to determine an effective peripheral route and dose of poly 
I:C administration to consistently induce fevers in rats.  Poly I:C was administered to 
rats at three different doses via three routes of delivery i.e. the subcutaneous-, 
intramuscular- and intraperitoneal routes.  Another objective was to determine the 
effects of peripheral administration of poly I:C on cage activity;  the suppression in 
voluntary activity is a sign of the presence of sickness behaviour (Engeland et al.: 
2003). The effects of injection of poly I:C on aspects of sickness behaviour have been 
investigated but to my knowledge, not fully understood. 
 
3.2 Experimental Protocol  
After recovery from telemeter surgery, rats were randomly assigned to three 
experimental groups (n=18/group) and received a single injection of either sterile 
saline, 500µg/kg poly I:C or 1000µg/kg poly I:C via one of the following routes: 
intraperitoneal, intramuscular or subcutaneous administration. Intraperitoneal 
injections were given in the abdominal cavity avoiding the bladder, intramuscular 
injections were given in the muscle mass of the upper thigh of the hind leg and the 
subcutaneous injections were given dorsally between the scapulae into the nape of the 
neck.  Injections were given on one or other side of the body. All injections were 
given at 09:00 and body temperature and cage activity were monitored for four days 
before- and three days after the poly I:C or saline injections. 
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Poly I:C administered at a dose of 1000µg/kg and by the intraperitoneal route was the 
only dose/route combination which proved successful in causing a significant 
increase in body temperature (see Figure 1), but with inconsistent results. Therefore, 
in a separate group of animals a dose of 2000µg/kg was administered 
intraperitoneally in an attempt to obtain more consistent fevers.  The additional group 
consisted of seven rats which received a single injection of 2000µg/kg poly I:C 
intraperitoneally.  Poly I:C administered subcutaneously and intramuscularly at doses 
of  500µg/kg and 1000µg/kg was ineffective in causing as increase  in body 
temperature, therefore higher doses were not pursued via these routes. 
 
3.2.1 Data analysis 
The mean body temperatures of rats receiving poly I:C at a dose of either 500µg/kg, 
1000µg/kg, via subcutaneous and intramuscular routes and at doses of 500µg/kg, 
1000µg/kg, and 2000µg/kg via the intraperitoneal route of administration, were 
compared to rats receiving sterile saline via the particular route of administration.  
Thermal response indices (TRIs, oC.h) were calculated for the six-hour time period 
after the start of the fever, for all rats receiving poly I:C via one of the three routes of 
administration and compared to the respective rats receiving saline.  Mean 12h day-
time and 12h night-time activity counts of rats receiving poly I:C via one of the three 
routes of administration were calculated and compared to the rats receiving sterile 
saline via the particular route of administration.  Statistically significant differences in 
body temperature and cage activity between the groups were determined using one-
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way ANOVA followed by the Tukèy post hoc test for multiple comparisons.  P 
values of  < 0.05 were considered statistically significant. 
 
3.3 Results 
 
Body temperature 
There was no increase in the mean body temperatures of the rats receiving poly I:C 
subcutaneously or intramuscularly at either dose of 500g/kg and 1000g/kg, when 
compared to the rats receiving sterile saline (Figure 1 A and B).  There was a 
significant increase in the mean body temperatures of rats receiving poly I:C 
intraperitoneally at a dose of 1000g/kg and 2000g/kg when compared to the rats 
receiving sterile saline (P<0.05) (Figure 1C).  The rats’ body temperatures started to 
rise approximately 2h after poly I:C administration and the fevers peaked 
approximately 4h after the injections.  The average maximum increase in body 
temperature after poly I:C administration at a dose of 1000g/kg and 2000g/kg was 
1oC and 1.5oC respectively, with the fevers lasting ± 6 and 7 h respectively.  
 
All the rats receiving either pyrogen or sterile saline injections showed a transient rise 
in body temperature which lasted for approximately 30min immediately after the 
injection (Figure 1).  This short-lived increase in body temperature was ascribed to 
the stress hyperthermia associated with handling during injections which is well 
documented (Long & Satinoff: 1990, Cabanac & Briese: 1992).  
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The body temperatures of all the rats returned to pre-treatment levels during the dark-
phase after the poly I:C or sterile saline administration except for the rats receiving 
2000µg/kg which showed a second rise in body temperature during the dark-phase 
lasting approximately 12h (Figure 1C). 
 
Cage Activity 
Figure 2 shows that there was no effect, either for day-time- or night-time activity in 
rats receiving poly I:C at either 500µg/kg or 1000µg/kg via subcutaneous and 
intramuscular routes or at either 500µg/kg, 1000µg/kg or 2000µg/kg via the 
intraperitoneal route, when compared to rats receiving sterile saline. 
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Fig 1. Mean body temperature changes in rats after administration of either 500g/kg () 
1000g/kg (×) and 2000g/kg () poly I:C or sterile saline () via subcutaneous (A), 
intramuscular (B) or intraperitoneal (C) route. * Indicates a significant increase in the mean 
body temperature of rats receiving poly I:C intraperitoneally at a dose of 1000g/kg and 
2000g/kg when compared to the rats receiving  sterile saline (P<0.05) for the period form 
11:00-17:00. The dashed line indicates the time of injection. Ordinate: body temperature in 
oC.  Abscissa: 24h clock time. 
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0
25
50
Night
Day
Ac
tiv
ity
 
(co
u
n
ts
/5
m
in
)
0
25
50
Ac
tiv
ity
 
(co
u
n
ts
/5
m
in
)
saline 500 µg/kg 1000 µg/kg 2000 µg/kg
0
25
50
Ac
tiv
ity
 
(co
u
n
ts
/5
m
in
)
A
B
C
 
 24 
Fig 2. Changes in mean 12h day-time (open bars) and mean 12h night-time (filled bars) cage 
activity counts for rats receiving either 500g/kg, 1000g/kg and 2000g/kg poly I:C or 
sterile saline via subcutaneous (A), intramuscular (B) or intraperitoneal (C) route. Ordinate: 
cage activity in counts/5min.  Abscissa: different experimental groups receiving poly I:C at 
respective doses. 
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3.4 Discussion 
 
Intraperitoneal administration of poly I:C at a dose of 1000µg/kg or 2000µg/kg in rats  
resulted in fevers significantly greater than the change in body temperature occurring 
as a result of sterile saline injection (P<0.05) by that same route. The 1000µg/kg dose 
produced less consistent fevers compared to the larger dose (2000µg/kg) but both 
doses resulted in significant rises in body temperature. 
 
Poly I:C administered intraperitoneally at a dose of 2000µg/kg resulted in fevers of 
longer duration when compared to the 1000µg/kg dose. Fevers induced by both high 
doses of poly I:C were monophasic, starting about two hours after injection and 
peaking about four hours after administration and lasting for six (1000µg/kg) to seven 
(2000µg/kg) hours, although the larger dose of poly I:C also resulted in a second rise 
in body temperature during the dark-phase (Figure 1C).   
 
Poly I:C administered either subcutaneously or intramuscularly, at a dose of 
500µg/kg and 1000µg/kg were ineffective in causing a rise in body temperature 
(Figure 1A and B).  
 
The fact that poly I:C administered either subcutaneously or intramuscularly fails to 
cause a fever at a dose which is effective via the intraperitoneal route may be the 
result of a lack of macrophages in the surrounding area to trigger the release of 
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cytokine mediators. Another reason could be that the doses used via the subcutaneous 
and intramuscular route were not adequate to cause an immune response. Another 
possibility is that subcutaneous administration of poly I:C results in tissue 
macrophages being primarily stimulated, decreasing the capacity to excite central 
receptors (Cartmell et al.: 2002). 
 
The doses used in this study are dissimilar to studies using other animals species such 
as rabbits, but appear to be consistent with other studies (Cooper et al.: 1988, 
Katafuchi et al.: 2003, Fortier et al.: 2004).  Although intramuscular injections 
administered in this study did not result in fevers, intramuscular injections of poly 
I:C, administered to guinea pigs does result in an increase in body temperature 
(Cooper et al.: 1988), confirming that there is a species variation in the effectiveness 
of poly I:C.  The results of this study are supported by Fortier et al. (2004) who 
reported that 500µg/kg of poly I:C administered intraperitoneally does not result in a 
significant increase in body temperature (Fortier et al.: 2004). 
 
Another important and unexpected finding of this study was that although 
intraperitoneal administration of poly I:C at doses of 1000µg/kg and 2000µg/kg 
resulted in significant fevers there was no accompanying suppression in cage activity 
(Figure 2). The suppression of activity is a common observation in rats made febrile 
by LPS injection (Hart: 1988b, Dantzer: 2004). Fortier et al. (2004) demonstrated that 
fever but not anorexia, which is another common characteristic which accompanies 
 27 
fever (LeGrand: 2000), induced by poly I:C, unlike that induced by LPS, is IL-1 and 
prostaglandin-dependent (Fortier et al.: 2004). Therefore, a possible explanation for 
not observing a decrease in cage activity is that the mediators which induce an 
increase in body temperature may differ from those mediating activity during a 
virally-induced infection. Interferons (IFNs) are the primary mediators thought to 
mediate virally-induced infection, but not much is known about the effects of this 
cytokine on inducing sickness behaviour.  
 
The lack of suppression in cage activity induced by poly I:C is contradictory to 
Katafuchi et al. (2003) who demonstrated that the administration of poly I:C results 
in an increase in body temperature of about 1oC as well as a suppression of physical 
activity in rats but at  a much higher dose of poly I:C (3000µg/kg) (Katafuchi et al.: 
2003). Thus another possible reason for the findings of my study was that the dose 
was inadequate to elicit sufficient cytokine mediators to result in the suppression in 
cage activity.  
 
In conclusion, I have shown that the efficacy of poly I:C to induce fever in rats is 
dependent on the dose and the route of administration. This study has shown that 
intraperitoneal administration of poly I:C at a minimum dose of 1000µg/kg is 
effective in inducing a fever response in rats but does not result in a suppression of 
cage activity in rats. 
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For all subsequent studies I describe in this dissertation, poly I:C was administered at 
a dose of 2000µg/kg via the intraperitoneal route.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
4. THE EFFECTS OF REPEATED ADMINISTRATION OF LPS 
AND POLY I:C IN RATS 
4.1 Introduction 
Repeated administration of the Gram-negative bacterial product, LPS, to laboratory 
animals results in the development of tolerance to its pyrogenic effects (Beeson: 
1947, Roth et al.: 1994, Chemo et al.: 1997, Tripp et al.: 1998, Almeida et al.: 1999), 
which is the progressive diminution in the febrile response. The tolerance 
phenomenon results not only in the attenuation of the fever response induced by LPS, 
but also an attenuation to aspects of the accompanying sickness behaviour (Chemo et 
al.: 1997, Tripp et al.: 1998, Almeida et al.: 1999).  Not much, however, is known 
about whether tolerance to the pyrogenic effects of a viral pyrogen develops after 
repeated administration in rats.   
 
The development of tolerance associated with repeated administration of LPS has 
been shown in a variety of animals including rabbits, guinea pigs and different strains 
of rats (He et al.: 1992, Chemo et al.: 1997, Tripp et al.: 1998). There exists a species 
variation in the rate of the development of tolerance, with the tolerance effect being 
more pronounced in rats, compared to rabbits and guinea pigs, which have a more 
gradual attenuation of the fever response (Tripp et al.: 1998). 
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Previous studies have also shown that tolerance to both the physiological and 
behavioural effects of Gram-negative LPS forms rapidly, often after a single exposure 
(O'Reilly et al.: 1988, Roth et al.: 1997, Tripp et al.: 1998) whereas the development 
of tolerance in response to repeated administration of the Gram-positive bacterial 
muramyl dipeptide (MDP) results more slowly or not at all (Soszynski et al.: 1991).  
If there are differences in the development of tolerance between bacterial products, it 
seems reasonable to speculate that there would be differences between the 
development of tolerance induced by bacterial and viral pyrogens in rats.  
 
Rats exhibit nycthermal body temperature variations, with body temperature being 
~1oC lower during the light-phase (day) than at night. Therefore fever responses 
induced during the dark-phase may be masked by the natural nocturnal rise in body 
temperature.  To maximize the ability to discern changes in body temperature 
responses as a result of repeated injections, therefore, tolerance studies in rats usually 
are performed during the day, and no studies, I believe, to date have investigated the 
effects of repeated night-time administration of LPS on body temperature and cage 
activity in rats, and it is not known if the tolerance to LPS would be as evident as it is 
after repeated day-time injections. 
 
Many different experimental protocols have been used to study the mechanisms 
mediating the development of tolerance. One such protocol is the use of osmotic 
pumps or pellets which are implanted subcutaneously in laboratory animals and allow 
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for the slow, continuous release of pyrogens over a period of days. Another protocol 
used is consecutive injections of a pyrogen, in which animals receive a single 
injection daily for a number of days. The interval between injections, however, has 
differed among the various studies (Soszynski et al.: 1991, Roth et al.: 1994, Tripp et 
al.: 1998). 
 
The objective of this study was therefore to determine whether repeated 
administration night-time administration of LPS would result in an attenuation of its 
pyrogenic and behavioural effects. I also wanted to compare the effects of repeated 
administration of LPS and poly I:C on body temperature and cage activity.  
 
4.2 Experimental Protocol 
After recovery from the surgery necessary for implantation of radiotelemeters (see 
chapter 2.2), rats were randomly assigned to three experimental groups and received a 
daily injection of either i) sterile saline intramuscularly (n=5), ii) poly I:C 2000µg/kg 
intraperitoneally (n=7), or iii) LPS 100µg/kg intramuscularly (n=5), for five 
consecutive days.  
 
LPS is known for its reliability in producing tolerance when injected repeatedly 
intramuscularly (Rosenthal et al.: 1996, Roth et al.: 1997, Soszynski & Krajewska: 
2001).  I have shown that poly I:C does not produce fevers when administered 
intramuscularly, but does produce fevers when administered intraperitoneally. 
 32 
Because repeated injection of LPS, both intramuscularly and intraperitoneally, 
produce tolerance (Roth et al.: 1994, Rosenthal et al.: 1996, Tripp et al.: 1998, 
Soszynski & Krajewska: 2001), it was not deemed necessary for a separate 
comparative study. 
    
Injections were given at 17:00, two hours before the start of the dark period in which 
the rats are most active. 
 
4.2.1 Data analysis 
The body temperatures of rats receiving either repeated LPS or poly I:C were 
compared to rats receiving repeated sterile saline. The mean body temperatures for all 
the groups of rats were calculated for the six hour period from 19:00-01:00. The mean 
body temperatures were calculated from 19:00 and not 17:00 to omit the stress 
hyperthermia from the fever response. Mean temperatures of rats receiving either 
LPS or poly I:C were compared to the mean temperature of rats receiving sterile 
saline.  
 
Thermal response indices (TRIs, oC.h) were calculated over a six hour period from 
19:00-01:00, following all five injections, for rats receiving either LPS, poly I:C or 
sterile  saline.   
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Mean 12h day-time and 12h night-time activity counts of rats receiving either LPS or 
poly I:C was calculated and compared to the rats receiving sterile saline. Statistical 
significance was determined using one-way ANOVA followed by the Tukèy post hoc 
test for multiple comparisons.  P<0.05 was considered statistically significant. 
 
4.2 Results 
 
Body Temperature  
There was a significant rise in the body temperatures of rats after receiving the first 
injection of 100µg/kg LPS intramuscularly (n=5) when compared to the rats receiving 
saline (n=5) (P<0.01) (Figure 3). The rats’ body temperatures started to rise 
approximately 2h after LPS administration and the fevers peaked approximately 4h 
after injection.  The maximum increase in body temperature after LPS administration 
was approximately 2oC. Not only was rat body temperature significantly elevated for  
approximately 6h after injection but the rats receiving LPS had a significantly 
elevated body temperature the morning after the first injection compared to the rats 
receiving saline (P<0.05) (Figure 4).  The increase in body temperature the morning 
after LPS administration was approximately 0.5oC, with the fever lasting 
approximately 10h. There was no significant increase in body temperature in rats 
after receiving the second, third, fourth and fifth injection of 100µg/kg LPS 
intramuscularly when compared to the rats receiving saline (Figure 4 and Figure 5).  
Figure 6 shows results of comparison of mean body temperature for the period after 
injection (19:00-01:00), between LPS, poly I:C and saline groups over the five 
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consecutive injections.  The figure shows that there was a significant increase in 
mean body temperature, over that of saline-injected rats, only after the first LPS 
injection. It would have been preferable to have a group of rats injected 
intraperitoneally with saline for control purposes. However, I expected either no, or a 
negligible effect on body temperature of rats injected intraperitoneally or 
intramuscularly with saline. Therefore, it was not considered ethical to do a separate 
group of rats receiving saline intraperitoneally. 
 
Figure 7 shows the six hour thermal response indices (oC.h), calculated for all three 
groups of rats. The figure shows that the rats receiving LPS responded with a 
significant increase in body temperature compared to the saline-treated controls only 
after the first injection and not following subsequent injections. 
 
There was a significant increase in the body temperatures of rats after receiving the 
first injection of 2000µg/kg poly I:C when compared to the rats receiving sterile 
saline (P<0.01) (Figure 3).  The rats’ body temperatures started to rise approximately 
two hours after poly I:C administration and the fevers peaked approximately three 
hours after injection.  The maximum increase in body temperature after poly I:C 
administration was approximately 1oC, with the fevers lasting about six hours. The 
rats receiving poly I:C responded with fevers with a similar profile after the second, 
third, fourth  and fifth injections when compared to the rats receiving saline (P<0.05) 
(Figure 4 and 5). The six hour thermal response indices (oC.h), and mean differences 
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in body temperature for rats receiving repeated poly I:C were significantly elevated 
on all five nights following each injection when compared to rats receiving sterile 
saline (P<0.01) (Figure 7 and 6 respectively). 
 
Once again all the rats receiving either pyrogen or saline injections showed a transient 
rise in body temperature of approximately 0.5oC, except for the fourth injection when 
animals were weighed in which there was an approximate 1oC increase, which lasted 
for approximately 30min after the injection (Figure 3, 4 and 5).  Notably the rats did 
not show a tolerance to this stress-induced rise in body temperature. This could be 
indicative of a different pathway being used compared to that induced during 
infection.   
 
 
Cage Activity 
There was a significant suppression in the night-time cage activity of rats after 
receiving the first three injections of LPS when compared to the rats receiving sterile 
saline (Figure 8, Day 1, 2 and 3).  There was no change in the night-time cage activity 
after the 4th and 5th injection of LPS (Figure 8, Day 4 and 5).  
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Poly I:C administration had no significant effect on the cage activity of rats, either 
night- or day-time, after any of the five injections when compared to the rats 
receiving sterile saline (Figure 8). 
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Fig 3. Mean body temperature changes (±SD) in rats receiving either 100µg/kg LPS 
intramuscularly (, n=5), 2000µg/kg poly I:C intraperitoneally (, n=7) or sterile saline 
intramuscularly (, n=5). * Indicates a significant increase in the body temperatures of rats 
receiving LPS, and #, a significant increase in the mean body temperatures of rats receiving 
poly I:C, when compared to the mean body temperatures of rats receiving sterile saline 
(P<0.01) for the period 19:00-01:00.  Dashed line indicates time of injection, and solid bar 
indicates the night-time period. Ordinate: body temperature of rats in oC. Abscissa : 24-h 
clock time. 
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Fig 4. Mean body temperature changes (±SD) in rats receiving either 100µg/kg of LPS 
intramuscularly (, n=5), 2000µg/kg poly I:C intraperitoneally (, n=7) or sterile saline 
intramuscularly (, n=5) the day after the first injection (Day 2) and the night of the second 
injection. # Indicates a significant increase in the body temperature of rats receiving LPS the 
morning following the first injection when compared to rats receiving sterile saline (P<0.05) 
for the period 09:00-17:00. * Indicates a significant increase in the body temperature of rats 
receiving the second injection of poly I:C when compared to rats receiving sterile saline 
(P<0.05) for the period 19:00-01:00. There was no significant difference (P>0.05) in the 
mean body temperatures of rats receiving the second injection of LPS compared to the rats 
receiving sterile saline injection.  Dashed line indicates time of second injection, and solid 
bar indicates the night-time period. Ordinate: body temperature of rats in oC. Abscissa: 24-h 
clock time. 
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Fig 5. Mean body temperature changes (±SD) in rats after receiving the third (Day 3), fourth 
(Day 4) and fifth (Day 5) injections of either 100µg/kg of LPS intramuscularly (, n=5), 
2000µg/kg poly I:C intraperitoneally (, n=7) or sterile saline intramuscularly (, n=5). 
There was no significant increase in the mean body temperature of rats receiving LPS on 
either days 3, 4 and 5 compared to rats receiving sterile saline.  * Indicates a significant 
increase in the body temperature of rats receiving the third, fourth and fifth injection of poly 
I:C when compared to rats receiving sterile saline (P<0.05) for the period 19:00-01:00.  
Dashed line indicates the time of injection, and solid bar indicates the night-time period. 
Large spike in body temperatures at the time of injection on day 4 was due to weighing of 
animals. Ordinate: body temperature of rats in oC. Abscissa: 24-h clock time. 
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Fig 6. Mean difference in body temperature (±SD) between rats receiving either 100µg/kg of 
LPS, and sterile saline intramuscularly (n=5, filled bars) or between rats receiving 2000µg/kg 
poly I:C intraperitoneally, and sterile saline intramuscularly (n=7, open bars). No difference 
between pyrogen and saline responses represented by the zero line. Differences were 
calculated for the period 19:00-01:00. * Indicates a significant differences in the effect of the 
pyrogen (P<0.05). Ordinate: mean difference in body temperature in oC. Abscissa: successive 
nights on which injections were given. Night 0 = the night before the first injection. 
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Fig 7. Mean thermal response index (oC.h, ±SD) for the six hour period between 19:00 and 
01:00 calculated for rats receiving injections (at 17:00) for five consecutive nights, of either 
100µg/kg LPS intramuscularly (n=5) (checked bars), 2000µg/kg poly I:C intraperitoneally 
(n=7, filled bars) or sterile saline intramuscularly (n=5, open bars). * Indicates a significant 
increase in the thermal response index of rats receiving LPS and poly I:C when compared to 
rats receiving sterile saline (P<0.05). Ordinate: thermal response index (oC.h). Abscissa: 
successive nights on which injections were given. Night 0 = the night before the first 
injection. 
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Fig 8. Changes in mean cage activity counts of rats receiving either 100µg/kg LPS 
intramuscularly (n=5), 2000µg/kg poly I:C intraperitoneally (n=7) or sterile saline 
intramuscularly (n=5) daily for five consecutive nights (Day1-5).  Open bars represent the 
mean 12 h day-time cage activity counts for the day before the night of injection and the 
filled bars represents the mean 12 h night-time cage activity counts for the night of the 
injection.  * Indicates a significant suppression in cage the activity of rats receiving 100µg/kg 
LPS intramuscularly when compared to rats receiving sterile saline (P<0.05). Ordinate: cage 
activity in counts/5min.  Abscissa: different experimental groups. 
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4.3 Discussion 
I have shown that LPS and poly I:C injected into rats two hours prior to the night-
time active period, causes fever with increases in body temperature being quite 
distinct from the normal night-time rise in rat body temperature (Figure 1). The 
magnitude and duration of fevers induced by LPS were distinctly larger when 
compared to those induced by poly I:C-induced fevers (Figure 1). Furthermore, I 
have shown that repeated daily administration of LPS to rats results in an attenuation 
of the febrile response, as well as to the suppression in cage activity.  LPS-treated rats 
became tolerant to the thermal effects of the pyrogen after a single injection, while 
the attenuation of the cage activity occurred after the third injection. In contrast, 
however, rats receiving poly I:C continued to respond with a significant rise in body 
temperature after each of the five consecutive injections. Poly I:C administration did 
not affect cage activity. 
 
The development of tolerance to the thermal effects of LPS after a single 
intramuscular night-time injection found in this study, is consistent with previous 
studies which have been performed during the day and with studies in which LPS was 
administered intraperitoneally (Soszynski et al.: 1991, Roth et al.: 1994, Chemo et 
al.: 1997, Tripp et al.: 1998). The time of LPS administration, whether during the 
active- or inactive phase, therefore has no effect on the development of tolerance to 
repeated LPS administration. Although there is a variation in the rate of development 
of thermal tolerance across different species thermal tolerance is a consistent feature 
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of repeated LPS administration (Soszynski et al.: 1991, Roth et al.: 1994, Tripp et al.: 
1998). 
 
In my study, tolerance did not develop to the thermal effects of poly I:C 
administration. Poly I:C consistently induced fevers of similar magnitude after each 
of the five injections (Figure 1-3). My data support previous findings, described for 
other animal species such as rabbits and guinea pigs (Cooper et al.: 1988, Soszynski 
et al.: 1991). Soszynski et al. (1991) reported that repeated intravenous 
administration of poly I:C in rabbits also did not result in thermal tolerance 
(Soszynski et al.: 1991). However, Cooper et al. (1988) reported that repeated 
administration of poly I:C in guinea pigs showed a transient tolerance to the febrile 
effect after three to four injections but continued administration of poly I:C resulted 
in fevers with increasing magnitude, a finding which they could not explain (Cooper 
et al.: 1988).  
 
The development of tolerance to repeated administration of LPS is thought to be 
mediated partly through a down-regulation of the gene transcription for- and the 
secretion of pro-inflammatory cytokines (Zeisberger & Roth: 1998) and an increase 
in the secretion of anti-inflammatory cytokines (Tripp et al.: 1998). Thus 
development of tolerance to repeated administration of LPS appears at least to be 
related to an altered function of macrophages, to inter alia, secrete cytokines involved 
in the fever response. Roth et al. (1994) showed that repeated administration of LPS 
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was accompanied by a strongly correlated reduction in circulating concentrations of 
tumor necrosis factor alpha (TNF-) and interleukin 6 (IL-6), which corroborated 
evidence from in vitro studies showing that repeated administration of LPS resulted 
in reduced macrophage transcription and translation for cytokine mRNAs and 
cytokine proteins (Roth et al.: 1994). It also was postulated that the hypothalamus 
might be unable to respond with an increase in prostaglandin E2 (PGE2) production to 
repeated administration of LPS. This latter theory, however, was not supported by 
Chemo et al. (1997) who showed that tolerance to LPS was more likely related to the 
altered responsiveness of neuronal receptors to PGE2 or due to alterations in 
intracellular signal transduction events (Chemo et al.: 1997).  
 
Why tolerance does not occur after repeated administration of poly I:C in rats remains 
unclear. I did not measure circulating cytokine concentrations of the rats in my study, 
but it is likely that repeated poly I:C administration may not result in a similar down-
regulation of the cytokine mechanisms such as occurs after repeated LPS 
administration (Fortier et al.: 2004). This study provides evidence that different 
mechanisms may mediate fevers induced by poly I:C,  compared to fevers induced by 
LPS.  
 
While the mechanisms of pyrogen-induced fever and the cytokines involved in those 
mechanisms have been well documented (Kluger et al.: 1995, Luheshi: 1998, Conti et 
al.: 2004), much less is understood about the cytokine mediators of sickness 
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behavior. In my study, cage activity was attenuated after the first injection of LPS, 
consistent with data from previous reports (Yirmiya et al.: 1994, Engeland et al.: 
2003) including that cage activity also is reduced by injection of Gram-positive 
agents (Luker et al.: 2000). In contrast to the thermal response, which was tolerant 
after the first injection, cage activity remained suppressed until after the third 
injection of LPS (Figure 6).  
 
The suppression of activity is a common observation in rats made febrile by LPS 
injection (Hart: 1988b).  Unexpectedly a dose of poly I:C which caused a robust fever 
consistently, had no effect on cage activity. In contrast, Katafuchi et al. (2003) 
demonstrated that the administration of poly I:C results in an increase in body 
temperature as well as a suppression of physical activity in rats but at a much higher 
dose of poly I:C (3000µg/kg) (Katafuchi et al.: 2003).  
 
My data point to the fact that different cytokine networks may underlie the responses 
to LPS and poly I:C. Fortier et al. (2004) demonstrated that the fever induced by poly 
I:C similar to LPS, is IL-1- and prostaglandin-dependent (Fortier et al.: 2004). 
However, the anorexia which accompanies the poly I:C-induced fever, appeared not 
to be effected by the same mediators (Fortier et al.: 2004). This finding is further 
supported by Swiergiel and Dunn (1999), who reported that IL-1, IL-6 and TNF- 
contribute to the hypophagia induced by LPS, but antagonism of all three of these 
cytokines did not attenuate the decrease in food intake and weight loss induced by 
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influenza virus infection (Swiergiel & Dunn: 1999). Thus, a possible explanation for 
not observing a decrease in cage activity after poly I:C injection is that the mediators 
which induce the sickness behaviour after poly I:C injection may differ from those 
induced by LPS to produce fever and suppression in cage activity. 
 
Interferons (IFNs) are the primary mediators thought to be involved in virally-
induced infection (Majde: 2000, Mogensen & Paludan: 2001), with little or no 
involvement in bacterial infections (Kimura et al.: 1994). Poly I:C and indeed other 
viral simulants may activate a cascade of cytokine release which exclude those, like 
IL-1 and/or TNF-, which appear to mediate a suppression of physical activity. 
Alternatively viral simulants may activate primarily pathways leading to IFN 
synthesis. It has been reported that intraperitoneal administration of poly I:C in rats 
induces the expression of IFN- mRNA in the brain (Katafuchi et al.: 2003). Kimura 
et al. (1994) reported that LPS, unlike poly I:C, fails to induce IFN- in the mouse 
macrophage cell line RAW 264.7, whereas administration of poly I:C minimally 
induces IL-6 mRNA (Kimura et al.: 1994). Interferon-alpha has been shown to result 
in hypoactivity and hypophagia in mice (Crnic & Segall: 1992) as well as in poly I:C-
induced hypoactivity in rats (Katafuchi et al.: 2003). Thus, those cytokines 
responsible for activity suppression may be released by viral simulants, but only at 
very high doses of them.  
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An intriguing question arises from my observations; why does tolerance to LPS-
induced hypoactivity occur only after three injections, when the thermal effects are 
tolerant after a single injection of LPS? I believe an explanation may lie in different 
cytokines mediating LPS-induced fever, versus LPS-induced suppression of activity. 
IL-6 is widely thought to be the most likely, if not the most essential, mediator of the 
rise in body temperature induced by LPS (Swiergiel & Dunn: 1999, Bluthe et al.: 
2000, Conti et al.: 2004). It is the expression of mRNA for- or synthesis of the 
protein of IL-6 which appears to be attenuated in the process of tolerance 
development, leading to decreased circulating concentrations (Roth et al.: 1994). My 
findings would suggest that IL-6 plays a lesser role in the regulation of cage activity, 
as it does in the generation of fever. Alternatively, cytokines other that IL-6, may 
mediate the suppression of sickness behaviour, and candidate substances may include 
the interleukins 1- and -. Mechanisms involving these cytokines may be more 
resistant to down-regulation during the process of tolerance development. 
 
A further question is raised by my observation of a disassociation in the time-course 
of tolerance to fever and activity suppression, that is why the infected organism 
would develop tolerance more readily to the thermal, compared to the non-thermal 
effects of Gram-negative infection. A prolonged period of fever would be 
metabolically expensive. A prolonged state of rest (inactivity) additionally conserves 
energy. Hart (1988) also has suggested that inactivity also would decrease the risk of 
predation, in some species.   
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In conclusion, I have shown that unlike during simulated bacterial infection, 
simulated viral infection appears not to induce one of the behaviours characteristic of 
infection, which is inactivity. Moreover, in contrast to the LPS-induced response, 
poly I:C in rats does not induced thermal tolerance, at least after repeated night-time 
administration. I have also shown a more rapid development of tolerance to the 
febrile effect of LPS compared to the development of tolerance to the inactivity 
which accompanies LPS fever. My results raise interesting questions concerning the 
mechanisms of induction of the acute phase response during bacterial as distinct to 
viral infections. 
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5. SUMMARY DISCUSSION AND CONCLUSIONS 
 
The overall purpose of this dissertation was to compare aspects of the acute phase 
response induced by LPS to those aspects which would be induced by a viral pyrogen 
in rats.  In order to achieve the objective of this study, I firstly had to establish an 
effective peripheral route of- and dose of administration of poly I:C, the chosen 
synthetic viral pyrogen, that consistently induced fevers in rats, a species seldom used 
for the study of poly I:C-induced fevers. The first of the differences I exposed 
between Gram-negative pyrogen and a viral pyrogen was that whereas LPS fever can 
be induced by injection via subcutaneous, intramuscular and intraperitoneal routes 
(O'Reilly et al.: 1988, Kamerman & Fuller: 2000, Cartmell et al.: 2002, Engeland et 
al.: 2003), poly I:C is effective only via the intraperitoneal route, at least in rats (see 
Chapter 3). I have shown that the synthetic viral pyrogen, poly I:C, is effective in 
causing an increase in body temperature in rats when administered intraperitoneally at 
a dose of at least 1000µg/kg, and 500µg/kg is ineffective in causing an increase in 
body temperature. Neither subcutaneous nor intramuscular administration of poly I:C 
were effective in causing an increase in body temperature, at least at doses below 
1000g/kg.  
 
A second difference in the characteristics between a Gram-negative and virally-
induced acute phase response, is that unlike for LPS and Gram-positive pyrogens 
(Luker et al.: 2000, Engeland et al.: 2003), poly I:C fails to affect physical activity. 
The different responses observed with exposure to LPS and poly I:C and the lack of 
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an effect of poly I:C administration on cage activity, could be indicative of different 
cytokine networks induced by the two chemically and molecularly different pyrogens. 
This theory is supported by Fortier et al. (2004) and Kimura et al. (1994) who 
demonstrated that there are some differences in the cytokine networks induced during 
LPS- and poly I:C induced APRs.  
 
Another well known characteristic of LPS is that repeated administration of this 
pyrogen in laboratory animals results in the development of tolerance to its pyrogenic 
effects. I was keen to observe whether repeated poly I:C administration also resulted 
in the development of tolerance.  Repeated night-time administration of LPS resulted 
in tolerance to its pyrogenic effects after only one injection; the second consecutive 
injection of LPS had no effect on the rats’ body temperature.  Interestingly, tolerance 
to the behavioural effects of LPS, specifically the attenuation in cage activity, only 
developed after the third consecutive injection. Repeated administration of poly I:C, 
unlike LPS, did not result in the development of tolerance to its pyrogenic effects. 
Again I believe the answer may lie with the cytokine mediators induced by LPS and 
poly I:C. 
 
In conclusion, although both LPS and poly I:C induce fevers in rats, there are 
fundamental differences in the characteristics of the thermal and behavioural effects 
induced by these two classes of pyrogens. These findings may indicate that the effects 
of these two molecularly and chemically different pyrogens are mediated via different 
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mechanisms. Future research should focus on the different cytokine networks 
involved in mediating the acute phase response in response to a bacterial versus a 
viral challenge.  
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